Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy Meeting Abstract


Authors: Naing, A.; Autio, K. A.; Falchook, G. S.; Meric-Bernstam, F.; Litton, J. K.; Ibrahim, N. K.; Hung, A.; Oft, M.; Leveque, J.; Patel, M. R.
Abstract Title: Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy
Meeting Title: 43rd ESMO Congress (ESMO 2018)
Journal Title: Annals of Oncology
Volume: 29
Issue: Suppl. 8
Meeting Dates: 2018 Oct 19-23
Meeting Location: Munich, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-10-01
Start Page: mdy288.018
Language: English
ACCESSION: WOS:000459277302324
PROVIDER: wos
DOI: 10.1093/annonc/mdy288.018
Notes: Meeting Abstract: 1145P -- Appears on pages viii407-viii408 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Anne Autio
    120 Autio